Xun Shangguan

767 total citations
19 papers, 491 citations indexed

About

Xun Shangguan is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Xun Shangguan has authored 19 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Xun Shangguan's work include Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Xun Shangguan is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Xun Shangguan collaborates with scholars based in China. Xun Shangguan's co-authors include Wei Xue, Jiahua Pan, Zhixiang Xin, Yinjie Zhu, Liancheng Fan, Baijun Dong, Yanqing Wang, Zehua Ma, Baijun Dong and Xiaoguang Shao and has published in prestigious journals such as Nature Communications, Cancer Research and International Journal of Cancer.

In The Last Decade

Xun Shangguan

19 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xun Shangguan China 12 209 183 178 159 61 19 491
Felix Meyer Germany 10 117 0.6× 341 1.9× 289 1.6× 159 1.0× 63 1.0× 20 646
Ugo De Paula Italy 9 151 0.7× 122 0.7× 59 0.3× 144 0.9× 80 1.3× 19 463
Peter W. Nagle Netherlands 11 88 0.4× 140 0.8× 174 1.0× 75 0.5× 25 0.4× 16 450
Tianqing Chu China 12 277 1.3× 227 1.2× 317 1.8× 163 1.0× 43 0.7× 46 606
Ko Abe Japan 10 191 0.9× 190 1.0× 53 0.3× 113 0.7× 46 0.8× 18 414
Luis Manuel Martínez-Barrera Mexico 10 270 1.3× 158 0.9× 271 1.5× 72 0.5× 19 0.3× 23 524
Jane‐Chloé Trone France 10 142 0.7× 150 0.8× 165 0.9× 107 0.7× 54 0.9× 43 501
Xianhua Xu South Korea 12 502 2.4× 299 1.6× 364 2.0× 203 1.3× 59 1.0× 25 795
Chenfei Chi China 14 287 1.4× 168 0.9× 177 1.0× 168 1.1× 43 0.7× 26 489
Carrie G. Lenneman United States 8 100 0.5× 122 0.7× 176 1.0× 28 0.2× 21 0.3× 18 526

Countries citing papers authored by Xun Shangguan

Since Specialization
Citations

This map shows the geographic impact of Xun Shangguan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xun Shangguan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xun Shangguan more than expected).

Fields of papers citing papers by Xun Shangguan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xun Shangguan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xun Shangguan. The network helps show where Xun Shangguan may publish in the future.

Co-authorship network of co-authors of Xun Shangguan

This figure shows the co-authorship network connecting the top 25 collaborators of Xun Shangguan. A scholar is included among the top collaborators of Xun Shangguan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xun Shangguan. Xun Shangguan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Shangguan, Xun, et al.. (2022). Squalene Epoxidase Metabolic Dependency Is a Targetable Vulnerability in Castration-Resistant Prostate Cancer. Cancer Research. 82(17). 3032–3044. 30 indexed citations
2.
Liu, Hailong, Yiyi Ji, Zehua Ma, et al.. (2022). Downregulation of SHMT2 promotes the prostate cancer proliferation and metastasis by inducing epithelial-mesenchymal transition. Experimental Cell Research. 415(2). 113138–113138. 15 indexed citations
3.
Shangguan, Xun, Jianli He, Zehua Ma, et al.. (2021). SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis. Nature Communications. 12(1). 1812–1812. 117 indexed citations
4.
Xu, Fan, Xun Shangguan, Jiahua Pan, et al.. (2021). HOXD13 suppresses prostate cancer metastasis and BMP4‐induced epithelial‐mesenchymal transition by inhibiting SMAD1. International Journal of Cancer. 148(12). 3060–3070. 38 indexed citations
5.
Ma, Zehua, Xun Shangguan, Zhixiang Xin, et al.. (2021). Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications. Cancer Medicine. 10(15). 5358–5374. 5 indexed citations
6.
Shangguan, Xun, et al.. (2019). Cell cycle progression score improves risk stratification in prostate cancer patients with adverse pathology after radical prostatectomy. Journal of Cancer Research and Clinical Oncology. 146(3). 687–694. 6 indexed citations
7.
Fan, Liancheng, Baijun Dong, Chenfei Chi, et al.. (2018). Serum levels of neuroendocrine differentiation markers predict the prognosis of patients with metastatic castration resistant prostate cancer treated with abiraterone acetate. Zhonghua miniao waike zazhi. 39(5). 362–366. 1 indexed citations
8.
Xin, Zhixiang, Yong Zhang, Zhou Jiang, et al.. (2018). Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate. Human Pathology. 79. 151–159. 57 indexed citations
9.
10.
Fan, Liancheng, Yanqing Wang, Chenfei Chi, et al.. (2017). Chromogranin A and neurone‐specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration‐resistant prostate cancer. British Journal of Urology. 120(2). 226–232. 24 indexed citations
11.
Fan, Liancheng, Xiao Wang, Chenfei Chi, et al.. (2017). Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration‐resistant prostate cancer patients treated with abiraterone. The Prostate. 77(12). 1233–1241. 35 indexed citations
12.
Wang, Yanqing, Wei Chen, Xiaofei Wen, et al.. (2017). Albumin and Fibrinogen Combined Prognostic Grade Predicts Prognosis of Patients with Prostate Cancer. Journal of Cancer. 8(19). 3992–4001. 22 indexed citations
13.
Fan, Liancheng, Chenfei Chi, Wen Cai, et al.. (2017). Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone. Journal of Cancer. 8(17). 3448–3455. 16 indexed citations
14.
Wang, Yanqing, Shaowei Xie, Xun Shangguan, et al.. (2017). Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population. Journal of Cancer Research and Clinical Oncology. 143(7). 1157–1166. 5 indexed citations
15.
Dong, Baijun, Liancheng Fan, Yanqing Wang, et al.. (2017). Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy‐naive metastatic castration‐resistant prostate cancer. The Prostate. 77(13). 1373–1380. 16 indexed citations
16.
17.
Shangguan, Xun, Baijun Dong, Jiahua Pan, et al.. (2016). Establishment and evaluation of nomogram for predicting biochemical recurrence in patients with locally adverse pathologic features after radical prostatectomy. Zhonghua miniao waike zazhi. 37(11). 827–832. 1 indexed citations
18.
Shao, Xiaoguang, Jiahua Pan, Yanqing Wang, et al.. (2016). Evaluation of expressed prostatic secretion and serum using surface-enhanced Raman spectroscopy for the noninvasive detection of prostate cancer, a preliminary study. Nanomedicine Nanotechnology Biology and Medicine. 13(3). 1051–1059. 33 indexed citations
19.
Shangguan, Xun, Baijun Dong, Yanqing Wang, et al.. (2016). Management of prostate cancer patients with locally adverse pathologic features after radical prostatectomy: feasibility of active surveillance for cases with Gleason grade 3 + 4 = 7. Journal of Cancer Research and Clinical Oncology. 143(1). 123–129. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felix Meyer Breakdown of academic impact, for papers by Ugo De Paula Breakdown of academic impact, for papers by Peter W. Nagle Breakdown of academic impact, for papers by Tianqing Chu Breakdown of academic impact, for papers by Ko Abe Breakdown of academic impact, for papers by Luis Manuel Martínez-Barrera Breakdown of academic impact, for papers by Jane‐Chloé Trone Breakdown of academic impact, for papers by Xianhua Xu Breakdown of academic impact, for papers by Chenfei Chi Breakdown of academic impact, for papers by Carrie G. Lenneman
Rankless by CCL
2026